Ternary Therapeutics are founded and led by pioneers in AI-driven drug discovery and targeted protein degradation, with fully-equipped labs in Stevenage and our HQ in London.

Their expertise has led to the successful delivery of multiple clinical candidates across a range of diseases, advancing innovative treatments through cutting-edge technology.

Ternary’s AI solutions have transformed drug discovery, with proven success in structural biology, knowledge graphs, and target assessment. With numerous patents and publications in structural bioinformatics, medicinal chemistry, and chemical biology, they continue to push the boundaries of scientific innovation.